Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  metformin hydrochloride
Find trials that include:  Any drugs shown
Results 1-25 of 26 for your search:
Start Over
Metformin Hydrochloride in Preventing Breast Cancer in Patients with Atypical Hyperplasia or In Situ Breast Cancer
Status: Active
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 25 to 55
Trial IDs: A211102, NCI-2013-00995, CALGB-A211102, NCT01905046
Paclitaxel and Carboplatin with or without Metformin Hydrochloride in Treating Patients with Stage III, IV, or Recurrent Endometrial Cancer
Status: Temporarily closed
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GOG-0286B, NCI-2013-02284, NCT02065687
Vandetanib and Metformin Hydrochloride in Treating Patients with Advanced Kidney Cancer
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15-C-0157, NCI-2015-01978, P152144, NCT02495103
Metformin Hydrochloride, Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients with Metastatic Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CASE 1212, NCI-2012-01322, NCT01666730
Metformin Hydrochloride in Reducing Obesity-Associated Breast Cancer Risk
Status: Active
Phase: Phase II
Type: Prevention
Age: 30 to 45
Trial IDs: 1300000596, NCI-2015-01211, 1300000596A024, NCT02028221
Metformin Hydrochloride and Combination Chemotherapy in Treating Patients with Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 77
Trial IDs: IRB13-1235, NCI-2014-00860, UC IRB13-1235, NCT02122185
Chemotherapy and Radiation Therapy with or without Metformin Hydrochloride in Treating Patients with Stage III Non-small Cell Lung Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NRG-LU001, NCI-2014-01071, PNRG-LU001_A01PAMDREVW01, NCT02186847
Metformin Hydrochloride in Treating Patients with Non-small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-0255, NCI-2015-00287, NCT02285855
Metformin Hydrochloride and Aspirin in Treating Patients with Hormone-Dependent Prostate Cancer That Has Progressed after Surgery or Radiation Therapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 081501, NCI-2015-00397, NCT02420652
Weight Loss or Metformin Hydrochloride in Reducing IGF-1 Hormone in Cancer Survivors
Status: Active
Phase: Phase II
Type: Behavioral study
Age: 18 and over
Trial IDs: J14148, NCI-2015-01160, NCT02431676
Metformin Hydrochloride in Preventing Oral Cancer in Patients with an Oral Premalignant Lesion
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: UAZ2015-05-02, NCI-2015-01733, HHSN2612012000311, NCT02581137
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)
Status: Active
Phase: Phase I
Type: Treatment
Age: 1 to 30
Trial IDs: MCC-16601, NCI-2011-02772, 14.03.0082, NCT01324180
Metformin Hydrochloride, Vincristine Sulfate, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients with Relapsed or Refractory Solid Tumors
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 2 to 18
Trial IDs: MCC 16962, NCI-2013-01179, NCT01528046
Temsirolimus and Metformin Hydrochloride in Treating Patients with Advanced or Metastatic Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 14 and over
Trial IDs: 2011-0923, NCI-2012-00216, NCT01529593
Metformin Hydrochloride in Reducing Cancer Risk in Patients with Li-Fraumeni Syndrome
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 and over
Trial IDs: 14-C-0005, NCI-2014-02320, P121103, 140005, NCT01981525
Metformin Hydrochloride with or without Sirolimus after Induction Chemotherapy Therapy in Treating Patients with Metastatic Pancreatic Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: J13146, NCI-2014-00912, NA_00090282, NCT02048384
Enzalutamide and Metformin Hydrochloride in Treating Patients with Hormone-Resistant Prostate Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UCDCC#243, NCI-2014-02668, NCT02339168
Metformin Hydrochloride and Doxycycline in Treating Patients with Localized Breast or Uterine Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 16D.317, NCI-2016-00977, NCT02874430
Metformin Hydrochloride and Lifestyle Intervention in Improving Biomarker Levels in Blood Samples From Stage I-IIIA Breast Cancer Survivors
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: Not specified
Trial IDs: 101977, NCI-2013-01967, UCSD101977, NCT01302379
Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Age: 18 to 75
Trial IDs: IUCRO-0365, NCI-2013-00422, NCT01793948
Metformin Hydrochloride and Atorvastatin Calcium in Treating Patients with Newly Diagnosed Breast Cancer That Can Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: IRB-AAAM2306, NCI-2014-01506, Y1M00, AAAM2306, NCT01980823
Metformin Hydrochloride and Levonorgestrel-Releasing Intrauterine System in Treating Patients with Atypical Endometrial Hyperplasia or Endometrial Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: LCCC 1326, NCI-2014-00799, 13-3723, 12-0886, NCT02035787
Metformin Hydrochloride in Reducing Metabolic Activity of Cancer Cells in Patients with Head and Neck Squamous Cell Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 18 to 80
Trial IDs: 13D.458, NCI-2014-02282, 2013-057, NCT02083692
Stereotactic Body Radiation Therapy and Metformin Hydrochloride in Treating Patients with Borderline-Resectable or Locally-Advanced Pancreatic Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: CASE 4213, NCI-2014-01172, 039877, NCT02153450
Start Over